Skip to main content

Table 2 TMA core-wise sensitivity analysis between LBS RTU p16 and RTD CINtec p16

From: Performance analysis of Leica Biosystems p16 monoclonal antibody in oropharyngeal squamous cell carcinoma

Subgroup

N

APA

ANA

OA

Estimate

95% CI

Estimate

95% CI

Estimate

95% CI

Reader 1

382

98.9%

[97.6–99.7%]

99.0%

[98.0–99.8%]

98.9%

[97.8–99.7]

Reader 2

387

97.8%

[96.0–99.2%]

98.1%

[96.6–99.3%]

97.9%

[96.4–99.2%]

  1. a. Percent agreements and 95% CI was produced using percentile bootstrapping approach
Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us